Cubist Pharmaceuticals, Inc. - SWOT Analysis

Cubist Pharmaceuticals, Inc. - SWOT Analysis
  • Report price : $ 125
  • Publication date : August 2008
  • Length : 29 pages

Get this Report Now !

Cubist Pharmaceuticals, Inc. - SWOT Analysis

Datamonitor's Cubist Pharmaceuticals, Inc. - SWOT Analysis company profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.

Cubist Pharmaceuticals (Cubist) is a biopharmaceutical company focused on the research, development and commercialization of anti-infective products in the acute care environment. The company markets Cubicin (daptomycin for injection), the first antibiotic in a new class of anti-infectives called lipopeptides, in the US. Cubist is headquartered in Lexington, Massachusetts and employs about 500 people. The company recorded revenues of $295 million during the financial year (FY) ended December 2007, an increase of 51.3% over 2006. The significant increase in revenues was primarily due to increase in Cubicin sales, which was a result of increased US customer volume and a 6.2% price increase in January 2007. The operating profit of the company was $41 million during FY2007, as compared to an operating profit of $5 million in 2006. The net profit was $48 million in FY2007, as compared to a net loss of $0.4 million in 2006.

Scope of the Report

- Provides all the crucial company information required for business and competitor intelligence needs
- Contains a study of the major internal and external factors affecting the company in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams
- Data is supplemented with details on the company’s history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement

Reasons to Purchase

- Support sales activities by understanding your customers’ businesses better
- Qualify prospective partners and suppliers
- Keep fully up to date on your competitors’ business structure, strategy and prospects
- Obtain the most up to date company information available

RELATED REPORTS

E. I. duPont de Nemours & Company - SWOT Analysis

E. I. duPont de Nemours & Company - SWOT Analysis

  • $ 125
  • August 2008
  • 33 pages

Datamonitor's E. I. duPont de Nemours & Company - SWOT Analysis company profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines ...

Industries : Healthcare

Cerner Corporation - SWOT Analysis

Cerner Corporation - SWOT Analysis

  • $ 125
  • August 2008
  • 29 pages

Datamonitor's Cerner Corporation - SWOT Analysis company profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy. ...

Industries : Healthcare

Bayer AG - SWOT Analysis

Bayer AG - SWOT Analysis

  • $ 125
  • August 2008
  • 37 pages

Datamonitor's Bayer AG - SWOT Analysis company profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy. Bayer is a ...

Industries : Healthcare

CVS Caremark Corporation - SWOT Analysis

CVS Caremark Corporation - SWOT Analysis

  • $ 125
  • August 2008
  • 27 pages

Datamonitor's CVS Caremark Corporation - SWOT Analysis company profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and stra ...

Industries : Healthcare

ViroPharma Incorporated - SWOT Analysis

ViroPharma Incorporated - SWOT Analysis

  • $ 125
  • August 2008
  • 24 pages

Datamonitor's ViroPharma Incorporated - SWOT Analysis company profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strat ...

Industries : Healthcare

Forecast Insight: Antihypertensives  Key patent expiries prevent market growth

Forecast Insight: Antihypertensives Key patent expiries prevent market growth

  • $ 15 200
  • July 2008
  • 96 pages

IntroductionDatamonitor expects the antihypertensives market to reach $37 billion, across the seven major markets, by 2017. The growth will be driven by the uptake of Novartis's Tekturna, as well as increased use of ARBs, and their combinations. However, the expiries of some key patents, particularl ...

Industries : Healthcare

Pipeline Insight: Cancer Overview - Lung, Brain, Head and Neck, Thyroid

Pipeline Insight: Cancer Overview - Lung, Brain, Head and Neck, Thyroid

  • $ 11 400
  • July 2008
  • 328 pages

IntroductionIn 2008, the six tumor types covered in this report are forecast to account for over 666,000 new cases of cancer, obviously representing an enormous market potential. However, it is the higher-incidence tumor types that continue to attract drug developers, with lower-incidence cancers po ...

Industries : Healthcare

Pfizer Inc.: PharmaVitae Profile

Pfizer Inc.: PharmaVitae Profile

  • $ 5 700
  • July 2008
  • 189 pages

IntroductionThis analysis examines the historical and forecast performance for Pfizer in the ethical pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs. An intera ...

Industries : Healthcare

Financial Deals Industry Tracker: Pharmaceuticals and Healthcare June 2008 (analysis of monthly deal activity along with the trend for the last six months for merger and acquisition (M&A), private equity, venture financing, private placement, initial publ

Financial Deals Industry Tracker: Pharmaceuticals and Healthcare June 2008 (analysis of monthly deal activity along with the trend for the last six months for merger and acquisition (M&A), private equity, venture financing, private placement, initial publ

  • $ 495
  • July 2008
  • 42 pages

SynopsisAnalysis and opinion on monthly deal activity, along with the trend for the last six months for merger and acquisition (M&A), private equity, private placement, IPO, and secondary offering deals.IntroductionThis report contains extensive qualitative and quantitative analysis of monthly deal ...

Industries : Healthcare

Adventist Health System Healthcare - Managed Care & Hospitals SWOT  Report

Adventist Health System Healthcare - Managed Care & Hospitals SWOT Report

  • $ 118
  • March 2008
  • 30 pages

Adventist Health System Healthcare - Managed Care & Hospitals SWOT Report is a comprehensive report of the company including both quantitative and qualitative research. The report examines the company’s business structure and operations, history and products. The report provides strategic insigh ...

Industries : Healthcare

24/7 Customer Service

Contact Clare now !

Related industries

reportlinker.com © Copyright 2009. All rights reserved

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.